218 related articles for article (PubMed ID: 32863363)
1. Intermittent Purpura Development Associated with Leukocytoclastic Vasculitis Induced by Infliximab for Crohn's Disease.
Kishimoto K; Kawashima K; Fukunaga M; Kotani S; Sonoyama H; Oka A; Mishima Y; Oshima N; Ishimura N; Ishikawa N; Maruyama R; Ishihara S
Intern Med; 2021 Feb; 60(3):385-389. PubMed ID: 32863363
[TBL] [Abstract][Full Text] [Related]
2. Hypersensitivity vasculitis with leukocytoclastic vasculitis secondary to infliximab.
McIlwain L; Carter JD; Bin-Sagheer S; Vasey FB; Nord J
J Clin Gastroenterol; 2003; 36(5):411-3. PubMed ID: 12702983
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous development of sarcoidosis and cutaneous vasculitis in a patient with refractory Crohn's disease during infliximab therapy.
Numakura T; Tamada T; Nara M; Muramatsu S; Murakami K; Kikuchi T; Kobayashi M; Muroi M; Okazaki T; Takagi S; Eishi Y; Ichinose M
BMC Pulm Med; 2016 Feb; 16():30. PubMed ID: 26864464
[TBL] [Abstract][Full Text] [Related]
4. [Adalimumab vasculitis in a patient with Crohn's disease].
Muñoz Villafranca C; Izu Belloso RM; Bravo Rodriguez MT; Basterra Olabarrieta S
Gastroenterol Hepatol; 2013 Apr; 36(4):296-7. PubMed ID: 23522950
[No Abstract] [Full Text] [Related]
5. An Unusual Cause of Skin Rash in Crohn's Disease.
Chebli JMF; de Oliveira Moreira B; da Rocha Ribeiro TC
Gastroenterology; 2018 Sep; 155(3):618-620. PubMed ID: 29409941
[No Abstract] [Full Text] [Related]
6. [IgA vasculitis associated with anti-TNF-α inhibitors in a patient with Crohn's disease].
Nishikawa J; Hosokawa A; Akashi M; Mihara H; Nanjo S; Yoshita H; Ando T; Kajiura S; Fujinami H; Sugiyama T
Nihon Shokakibyo Gakkai Zasshi; 2015 Oct; 112(10):1852-7. PubMed ID: 26440688
[TBL] [Abstract][Full Text] [Related]
7. Leukocytoclastic Vasculitis Related to Ustekinumab in a Crohn's Disease Patient: First Case Report and Literature Review.
Costa-Moreira P; Lopes S; Santos AL; Pedrosa AF; Andrade P; Portugal R; Macedo G
J Crohns Colitis; 2020 Feb; 14(2):274-276. PubMed ID: 31267125
[TBL] [Abstract][Full Text] [Related]
8. Severe Henoch-Schönlein purpura with infliximab for ulcerative colitis.
Song Y; Shi YH; He C; Liu CQ; Wang JS; Zhao YJ; Guo YM; Wu RJ; Feng XY; Liu ZJ
World J Gastroenterol; 2015 May; 21(19):6082-7. PubMed ID: 26019477
[TBL] [Abstract][Full Text] [Related]
9. Leukocytoclastic vasculitis complicating adalimumab therapy for Crohn's disease: Report of three cases.
Bernardes C; Carvalho D; Saiote J; Ramos J
Gastroenterol Hepatol; 2018; 41(7):442-443. PubMed ID: 29054318
[No Abstract] [Full Text] [Related]
10. Cutaneous Vasculitis in a Patient with Crohn's Disease Treated with Adalimumab.
Cury DB; de Souza AW; Vianna GA; Odashiro D; Farias A; Moss AC
Inflamm Bowel Dis; 2017 Jan; 23(1):E1-E2. PubMed ID: 27893546
[No Abstract] [Full Text] [Related]
11. A Rare Case of Infliximab-Induced Small Vessel Vasculitis With Renal Involvement.
Way A; Weinstein E
J Investig Med High Impact Case Rep; 2023; 11():23247096231188247. PubMed ID: 37585744
[TBL] [Abstract][Full Text] [Related]
12. Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effect.
Iborra M; Beltrán B; Bastida G; Aguas M; Nos P
J Crohns Colitis; 2011 Apr; 5(2):157-61. PubMed ID: 21453886
[TBL] [Abstract][Full Text] [Related]
13. Anti-TNF-Related Leukocytoclastic Vasculitis in Ulcerative Colitis: A Case Report.
Giorgio V; Blasi E; Rigante D; Guerriero C; De Simone C; Fedele AL; Stella G; Gasbarrini A; Scaldaferri F
Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34206410
[TBL] [Abstract][Full Text] [Related]
14. Adalimumab-induced leukocytoclastic vasculitis in a Crohn's disease patient.
Cançado GGL; Nardelli MJ; Gouthier MAD
Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):453. PubMed ID: 33512843
[No Abstract] [Full Text] [Related]
15. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases.
Ramos-Casals M; Brito-Zerón P; Muñoz S; Soria N; Galiana D; Bertolaccini L; Cuadrado MJ; Khamashta MA
Medicine (Baltimore); 2007 Jul; 86(4):242-251. PubMed ID: 17632266
[TBL] [Abstract][Full Text] [Related]
16. [A case of psoriasis induced by infliximab treatment for Crohn's disease].
Jwa YJ; Kim NH; Park HJ; Park JS; Bae WK; Kim KA; Lee JS; Moon YS
Korean J Gastroenterol; 2010 Nov; 56(5):324-8. PubMed ID: 21099241
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-α inhibitor-induced morphea and psoriasiform dermatitis in a pediatric patient with Crohn's disease.
Reinhart JP; Aird JL; Stephens MC; Asch S; Orandi AB; Tollefson MM
Pediatr Dermatol; 2023; 40(3):519-522. PubMed ID: 36385392
[TBL] [Abstract][Full Text] [Related]
18. Leukocytoclastic vasculitis: A rare adverse effect secondary to infliximab.
Karoui S; Bibani N; Ben Gorbel I; Serghini M; Mlika M; Braham A; Chelly I; Haouet S; Houmène H; Filali A
Inflamm Bowel Dis; 2011 Feb; 17(2):E4-5. PubMed ID: 20848511
[No Abstract] [Full Text] [Related]
19. Lymphomatoid Papulosis Type B in a Patient with Crohn's Disease Treated with TNF-Alpha Inhibitors Infliximab and Adalimumab.
Medvecz M; Kiss N; Hársing J; Kuroli E; Hegede G; Csomor J; Kárpáti S; Marschalkó M
Acta Dermatovenerol Croat; 2019 Sep; 27(3):202-204. PubMed ID: 31542070
[TBL] [Abstract][Full Text] [Related]
20. Warfarin induced leukocytoclastic vasculitis: an extraordinary side effect.
Elantably D; Mourad A; Elantably A; Effat M
J Thromb Thrombolysis; 2020 Jan; 49(1):149-152. PubMed ID: 31375992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
